Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1761, Issue 7, 2006, Pages 655-666

  Cavelier, Clara ^a   Lorenzi, Iris ^a   Rohrer, Lucia ^a   von Eckardstein, Arnold ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

ABCA1; ABCG1; apoA I; Cholesterol efflux; HDL; Retroendocytosis

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN; APOLIPOPROTEIN A1; BREAST CANCER RESISTANCE PROTEIN; CHOLESTEROL; CYCLIC AMP; HIGH DENSITY LIPOPROTEIN; LIPID; LIVER X RECEPTOR; PHOSPHATIDYLSERINE; PHOSPHOLIPID;

CELL MEMBRANE; CELL SURFACE; ENDOCYTOSIS; GENE EXPRESSION; GENE MUTATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; REVIEW;

ADIPOSE TISSUE; ANIMALS; APOLIPOPROTEIN A-I; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CARDIOVASCULAR DISEASES; CHOLESTEROL; ENDOCYTOSIS; HUMANS; LIPIDS; LIPOPROTEINS, HDL; LIVER; MACROPHAGES; PROTEIN BINDING;

EID: 33746287715     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2006.04.012     Document Type: Review

References (120)

1. Gordon D.J., and Rifkind B.M. High-density lipoprotein-The clinical implications of recent studies. N. Engl. J. Med. 321 (1989) 1311-1316
2. Brousseau M.E., and Hoeg J.M. Transgenic rabbits as models for atherosclerosis research. J. Lipid Res. 40 (1999) 365-375
3. von Eckardstein A., Hersberger M., and Rohrer L. Current understanding of the metabolism and biological actions of HDL. Curr. Opin. Clin. Nutr. Metab. Care 8 (2005) 147-152
4. McNeish J., Aiello R.J., Guyot D., Turi T., Gabel C., Aldinger C., Hoppe K.L., Roach M.L., Royer L.J., de Wet J., Broccardo C., Chimini G., and Francone O.L. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 4245-4250
5. Timmins J.M., Lee J.Y., Boudyguina E., Kluckman K.D., Brunham L.R., Mulya A., Gebre A.K., Coutinho J.M., Colvin P.L., Smith T.L., Hayden M.R., Maeda N., and Parks J.S. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. J. Clin. Invest. 115 (2005) 1333-1342
6. Martin S., and Parton R.G. Caveolin, cholesterol, and lipid bodies. Semin. Cell Dev. Biol. 16 (2005) 163-174
7. Greenow K., Pearce N.J., and Ramji D.P. The key role of apolipoprotein E in atherosclerosis. J. Mol. Med. 83 (2005) 329-342
8. Bjorkhem I., Diczfalusy U., and Lutjohann D. Removal of cholesterol from extrahepatic sources by oxidative mechanisms. Curr. Opin. Lipidol. 10 (1999) 161-165
9. Ji Y., Jian B., Wang N., Sun Y., Moya M.L., Phillips M.C., Rothblat G.H., Swaney J.B., and Tall A.R. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272 (1997) 20982-20985
10. Gu X., Kozarsky K., and Krieger M. Scavenger receptor class B, type I-mediated [3H]cholesterol efflux to high and low density lipoproteins is dependent on lipoprotein binding to the receptor. J. Biol. Chem. 275 (2000) 29993-30001
11. de La Llera-Moya M., Connelly M.A., Drazul D., Klein S.M., Favari E., Yancey P.G., Williams D.L., and Rothblat G.H. Scavenger receptor class B type I affects cholesterol homeostasis by magnifying cholesterol flux between cells and HDL. J. Lipid Res. 42 (2001) 1969-1978
12. Gillotte K.L., Davidson W.S., Lund-Katz S., Rothblat G.H., and Phillips M.C. Removal of cellular cholesterol by pre-beta-HDL involves plasma membrane microsolubilization. J. Lipid Res. 39 (1998) 1918-1928
13. Gillotte K.L., Zaiou M., Lund-Katz S., Anantharamaiah G.M., Holvoet P., Dhoest A., Palgunachari M.N., Segrest J.P., Weisgraber K.H., Rothblat G.H., and Phillips M.C. Apolipoprotein-mediated plasma membrane microsolubilization. Role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid. J. Biol. Chem. 274 (1999) 2021-2028
14. Santamarina-Fojo S., Peterson K., Knapper C., Qiu Y., Freeman L., Cheng J.F., Osorio J., Remaley A., Yang X.P., Haudenschild C., Prades C., Chimini G., Blackmon E., Francois T., Duverger N., Rubin E.M., Rosier M., Denefle P., Fredrickson D.S., and Brewer Jr. H.B. Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 7987-7992
15. Bungert S., Molday L.L., and Molday R.S. Membrane topology of the ATP binding cassette transporter ABCR and its relationship to ABC1 and related ABCA transporters: identification of N-linked glycosylation sites. J. Biol. Chem. 276 (2001) 23539-23546
16. Fitzgerald M.L., Mendez A.J., Moore K.J., Andersson L.P., Panjeton H.A., and Freeman M.W. ATP-binding cassette transporter A1 contains an NH2-terminal signal anchor sequence that translocates the protein's first hydrophilic domain to the exoplasmic space. J. Biol. Chem. 276 (2001) 15137-15145
17. Bodzioch M., Orso E., Klucken J., Langmann T., Bottcher A., Diederich W., Drobnik W., Barlage S., Buchler C., Porsch-Ozcurumez M., Kaminski W.E., Hahmann H.W., Oette K., Rothe G., Aslanidis C., Lackner K.J., and Schmitz G. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22 (1999) 347-351
18. Remaley A.T., Rust S., Rosier M., Knapper C., Naudin L., Broccardo C., Peterson K.M., Koch C., Arnould I., Prades C., Duverger N., Funke H., Assman G., Dinger M., Dean M., Chimini G., Santamarina-Fojo S., Fredrickson D.S., Denefle P., and Brewer Jr. H.B. Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 12685-12690
19. Rust S., Rosier M., Funke H., Real J., Amoura Z., Piette J.C., Deleuze J.F., Brewer H.B., Duverger N., Denefle P., and Assmann G. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet. 22 (1999) 352-355
20. Brooks-Wilson A., Marcil M., Clee S.M., Zhang L.H., Roomp K., van Dam M., Yu L., Brewer C., Collins J.A., Molhuizen H.O., Loubser O., Ouelette B.F., Fichter K., Ashbourne-Excoffon K.J., Sensen C.W., Scherer S., Mott S., Denis M., Martindale D., Frohlich J., Morgan K., Koop B., Pimstone S., Kastelein J.J., Genest Jr. J., and Hayden M.R. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22 (1999) 336-345
21. Francis G.A., Knopp R.H., and Oram J.F. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. J. Clin. Invest. 96 (1995) 78-87
22. Remaley A.T., Schumacher U.K., Stonik J.A., Farsi B.D., Nazih H., and Brewer Jr. H.B. Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 1813-1821
23. Vaisman B.L., Lambert G., Amar M., Joyce C., Ito T., Shamburek R.D., Cain W.J., Fruchart-Najib J., Neufeld E.D., Remaley A.T., Brewer Jr. H.B., and Santamarina-Fojo S. ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice. J. Clin. Invest. 108 (2001) 303-309
24. Singaraja R.R., Fievet C., Castro G., James E.R., Hennuyer N., Clee S.M., Bissada N., Choy J.C., Fruchart J.C., McManus B.M., Staels B., and Hayden M.R. Increased ABCA1 activity protects against atherosclerosis. J. Clin. Invest. 110 (2002) 35-42
25. Haghpassand M., Bourassa P.A., Francone O.L., and Aiello R.J. Monocyte/Macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. J. Clin. Invest. 108 (2001) 1315-1320
26. Aiello R.J., Brees D., Bourassa P.A., Royer L., Lindsey S., Coskran T., Haghpassand M., and Francone O.L. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 630-637
27. Costet P., Luo Y., Wang N., and Tall A.R. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J. Biol. Chem. 275 (2000) 28240-28245
28. Fu X., Menke J.G., Chen Y., Zhou G., MacNaul K.L., Wright S.D., Sparrow C.P., and Lund E.G. 27-Hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J. Biol. Chem. 276 (2001) 38378-38387
29. Ide T., Shimano H., Yoshikawa T., Yahagi N., Amemiya-Kudo M., Matsuzaka T., Nakakuki M., Yatoh S., Iizuka Y., Tomita S., Ohashi K., Takahashi A., Sone H., Gotoda T., Osuga J., Ishibashi S., and Yamada N. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism: II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling. Mol. Endocrinol. 17 (2003) 1255-1267
30. Yoshikawa T., Ide T., Shimano H., Yahagi N., Amemiya-Kudo M., Matsuzaka T., Yatoh S., Kitamine T., Okazaki H., Tamura Y., Sekiya M., Takahashi A., Hasty A.H., Sato R., Sone H., Osuga J., Ishibashi S., and Yamada N. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism: I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling. Mol. Endocrinol. 17 (2003) 1240-1254
31. Ou J., Tu H., Shan B., Luk A., DeBose-Boyd R.A., Bashmakov Y., Goldstein J.L., and Brown M.S. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 6027-6032
32. Schmitz G., and Langmann T. Transcriptional regulatory networks in lipid metabolism control ABCA1 expression. Biochim. Biophys. Acta 1735 (2005) 1-19
33. Oram J.F., Lawn R.M., Garvin M.R., and Wade D.P. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J. Biol. Chem. 275 (2000) 34508-34511
34. Haidar B., Denis M., Krimbou L., Marcil M., and Genest Jr. J. cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts. J. Lipid Res. 43 (2002) 2087-2094
35. Haidar B., Denis M., Marcil M., Krimbou L., and Genest Jr. J. Apolipoprotein A-I activates cellular cAMP signaling through the ABCA1 transporter. J. Biol. Chem. 279 (2004) 9963-9969
36. Tang C., Vaughan A.M., and Oram J.F. Janus kinase 2 modulates the apolipoprotein interactions with ABCA1 required for removing cellular cholesterol. J. Biol. Chem. 279 (2004) 7622-7628
37. Roosbeek S., Peelman F., Verhee A., Labeur C., Caster H., Lensink M.F., Cirulli C., Grooten J., Cochet C., Vandekerckhove J., Amoresano A., Chimini G., Tavernier J., and Rosseneu M. Phosphorylation by protein kinase CK2 modulates the activity of the ATP binding cassette A1 transporter. J. Biol. Chem. 279 (2004) 37779-37788
38. Martinez L.O., Agerholm-Larsen B., Wang N., Chen W., and Tall A.R. Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I. J. Biol. Chem. 278 (2003) 37368-37374
39. Wang Y., and Oram J.F. Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1. J. Biol. Chem. 277 (2002) 5692-5697
40. Wang Y., and Oram J.F. Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a phospholipase D2 pathway. J. Biol. Chem. 280 (2005) 35896-35903
41. Munehira Y., Ohnishi T., Kawamoto S., Furuya A., Shitara K., Imamura M., Yokota T., Takeda S., Amachi T., Matsuo M., Kioka N., and Ueda K. Alpha1-syntrophin modulates turnover of ABCA1. J. Biol. Chem. 279 (2004) 15091-15095
42. Okuhira K., Fitzgerald M.L., Sarracino D.A., Manning J.J., Bell S.A., Goss J.L., and Freeman M.W. Purification of ATP-binding cassette transporter A1 and associated binding proteins reveals the importance of beta1-syntrophin in cholesterol efflux. J. Biol. Chem. 280 (2005) 39653-39664
43. Buechler C., Boettcher A., Bared S.M., Probst M.C., and Schmitz G. The carboxyterminus of the ATP-binding cassette transporter A1 interacts with a beta2-syntrophin/utrophin complex. Biochem. Biophys. Res. Commun. 293 (2002) 759-765
44. Tsukamoto K., Hirano K., Tsujii K., Ikegami C., Zhongyan Z., Nishida Y., Ohama T., Matsuura F., Yamashita S., and Matsuzawa Y. ATP-binding cassette transporter-1 induces rearrangement of actin cytoskeletons possibly through Cdc42/N-WASP. Biochem. Biophys. Res. Commun. 287 (2001) 757-765
45. Kennedy M.A., Venkateswaran A., Tarr P.T., Xenarios I., Kudoh J., Shimizu N., and Edwards P.A. Characterization of the human ABCG1 gene: liver X receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein. J. Biol. Chem. 276 (2001) 39438-39447
46. Vaughan A.M., and Oram J.F. ABCG1 redistributes cell cholesterol to domains removable by HDL but not by lipid-depleted apolipoproteins. J. Biol. Chem. 280 34 (2005) 30150-30157
47. Nakamura K., Kennedy M.A., Baldan A., Bojanic D.D., Lyons K., and Edwards P.A. Expression and regulation of multiple murine ATP-binding cassette transporter G1 mRNAs/isoforms that stimulate cellular cholesterol efflux to high density lipoprotein. J. Biol. Chem. 279 (2004) 45980-45989
48. Wang N., Lan D., Chen W., Matsuura F., and Tall A.R. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 9774-9779
49. Kennedy M.A., Barrera G.C., Nakamura K., Baldan A., Tarr P., Fishbein M.C., Frank J., Francone O.L., and Edwards P.A. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell. Metab. 1 (2005) 121-131
50. Li A.C., Binder C.J., Gutierrez A., Brown K.K., Plotkin C.R., Pattison J.W., Valledor A.F., Davis R.A., Willson T.M., Witztum J.L., Palinski W., and Glass C.K. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. J. Clin. Invest. 114 (2004) 1564-1576
51. Suzuki S., Nishimaki-Mogami T., Tamehiro N., Inoue K., Arakawa R., Abe-Dohmae S., Tanaka A.R., Ueda K., and Yokoyama S. Verapamil increases the apolipoprotein-mediated release of cellular cholesterol by induction of ABCA1 expression via Liver X receptor-independent mechanism. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 519-525
52. Chambenoit O., Hamon Y., Marguet D., Rigneault H., Rosseneu M., and Chimini G. Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1 transporter. J. Biol. Chem. 276 (2001) 9955-9960
53. Wang N., Silver D.L., Thiele C., and Tall A.R. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J. Biol. Chem. 276 (2001) 23742-23747
54. Chroni A., Liu T., Fitzgerald M.L., Freeman M.W., and Zannis V.I. Cross-linking and lipid efflux properties of apoA-I mutants suggest direct association between apoA-I helices and ABCA1. Biochemistry 43 (2004) 2126-2139
55. Fitzgerald M.L., Morris A.L., Rhee J.S., Andersson L.P., Mendez A.J., and Freeman M.W. Naturally occurring mutations in the largest extracellular loops of ABCA1 can disrupt its direct interaction with apolipoprotein A-I. J. Biol. Chem. 277 (2002) 33178-33187
56. Fitzgerald M.L., Okuhira K., Short III G.F., Manning J.J., Bell S.A., and Freeman M.W. ATP-binding cassette transporter A1 contains a novel C-terminal VFVNFA motif that is required for its cholesterol efflux and ApoA-I binding activities. J. Biol. Chem. 279 (2004) 48477-48485
57. Rigot V., Hamon Y., Chambenoit O., Alibert M., Duverger N., and Chimini G. Distinct sites on ABCA1 control distinct steps required for cellular release of phospholipids. J. Lipid Res. 43 (2002) 2077-2086
58. Chroni A., Liu T., Gorshkova I., Kan H.Y., Uehara Y., Von Eckardstein A., and Zannis V.I. The central helices of ApoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type ApoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo. J. Biol. Chem. 278 (2003) 6719-6730
59. Vedhachalam C., Liu L., Nickel M., Dhanasekaran P., Anantharamaiah G.M., Lund-Katz S., Rothblat G.H., and Phillips M.C. Influence of ApoA-I structure on the ABCA1-mediated efflux of cellular lipids. J. Biol. Chem. 279 (2004) 49931-49939
60. Remaley A.T., Thomas F., Stonik J.A., Demosky S.J., Bark S.E., Neufeld E.B., Bocharov A.V., Vishnyakova T.G., Patterson A.P., Eggerman T.L., Santamarina-Fojo S., and Brewer H.B. Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway. J. Lipid Res. 44 (2003) 828-836
61. Remaley A.T., Stonik J.A., Demosky S.J., Neufeld E.B., Bocharov A.V., Vishnyakova T.G., Eggerman T.L., Patterson A.P., Duverger N.J., Santamarina-Fojo S., and Brewer Jr. H.B. Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. Biochem. Biophys. Res. Commun. 280 (2001) 818-823
62. Nofer J.R., Remaley A.T., Feuerborn R., Wolinska I., and Engel T. A. von Eckardstein, G. Assmann, Apolipoprotein A-I (APO A-I) activates CDC42 signaling through ABCA1 transporter. J. Lipid Res. 47 4 (2006) 794-803
63. Oram J.F., Johnson C.J., and Brown T.A. Interaction of high density lipoprotein with its receptor on cultured fibroblasts and macrophages. Evidence for reversible binding at the cell surface without internalization. J. Biol. Chem. 262 (1987) 2405-2410
64. Aviram M., Bierman E.L., and Oram J.F. High density lipoprotein stimulates sterol translocation between intracellular and plasma membrane pools in human monocyte-derived macrophages. J. Lipid Res. 30 (1989) 65-76
65. Slotte J.P., Oram J.F., and Bierman E.L. Binding of high density lipoproteins to cell receptors promotes translocation of cholesterol from intracellular membranes to the cell surface. J. Biol. Chem. 262 (1987) 12904-12907
66. Oram J.F., Mendez A.J., Slotte J.P., and Johnson T.F. High density lipoprotein apolipoproteins mediate removal of sterol from intracellular pools but not from plasma membranes of cholesterol-loaded fibroblasts. Arterioscler. Thromb. 11 (1991) 403-414
67. van Helvoort A., Smith A.J., Sprong H., Fritzsche I., Schinkel A.H., Borst P., and van Meer G. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87 (1996) 507-517
68. Kielar D., Kaminski W.E., Liebisch G., Piehler A., Wenzel J.J., Mohle C., Heimerl S., Langmann T., Friedrich S.O., Bottcher A., Barlage S., Drobnik W., and Schmitz G. Adenosine triphosphate binding cassette (ABC) transporters are expressed and regulated during terminal keratinocyte differentiation: a potential role for ABCA7 in epidermal lipid reorganization. J. Invest. Dermatol. 121 (2003) 465-474
69. Wang N., Silver D.L., Costet P., and Tall A.R. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J. Biol. Chem. 275 (2000) 33053-33058
70. Alder-Baerens N., Muller P., Pohl A., Korte T., Hamon Y., Chimini G., Pomorski T., and Herrmann A. Headgroup-specific exposure of phospholipids in ABCA1-expressing cells. J. Biol. Chem. 280 (2005) 26321-26329
71. Hamon Y., Broccardo C., Chambenoit O., Luciani M.F., Toti F., Chaslin S., Freyssinet J.M., Devaux P.F., McNeish J., Marguet D., and Chimini G. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat. Cell Biol. 2 (2000) 399-406
72. von Eckardstein A., Chirazi A., Schuler-Luttmann S., Walter M., Kastelein J.J., Geisel J., Real J.T., Miccoli R., Noseda G., Hobbel G., and Assmann G. Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I. J. Lipid Res. 39 (1998) 987-998
73. Smith J.D., Waelde C., Horwitz A., and Zheng P. Evaluation of the role of phosphatidylserine translocase activity in ABCA1-mediated lipid efflux. J. Biol. Chem. 277 (2002) 17797-17803
74. Vaughan A.M., and Oram J.F. ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions. J. Lipid Res. 44 (2003) 1373-1380
75. Lin G., and Oram J.F. Apolipoprotein binding to protruding membrane domains during removal of excess cellular cholesterol. Atherosclerosis 149 (2000) 359-370
76. Chen W., Wang N., and Tall A.R. A PEST deletion mutant of ABCA1 shows impaired internalization and defective cholesterol efflux from late endosomes. J. Biol. Chem. 280 (2005) 29277-29281
77. Neufeld E.B., Remaley A.T., Demosky S.J., Stonik J.A., Cooney A.M., Comly M., Dwyer N.K., Zhang M., Blanchette-Mackie J., Santamarina-Fojo S., and Brewer Jr. H.B. Cellular localization and trafficking of the human ABCA1 transporter. J. Biol. Chem. 276 (2001) 27584-27590
78. Schmitz G., Robenek H., Lohmann U., and Assmann G. Interaction of high density lipoproteins with cholesteryl ester-laden macrophages: biochemical and morphological characterization of cell surface receptor binding, endocytosis and resecretion of high density lipoproteins by macrophages. EMBO J. 4 (1985) 613-622
79. Schmitz G., Assmann G., Robenek H., and Brennhausen B. Tangier disease: a disorder of intracellular membrane traffic. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 6305-6309
80. Alam R., Yatsu F.M., Tsui L., and Alam S. Receptor-mediated uptake and 'retroendocytosis' of high-density lipoproteins by cholesterol-loaded human monocyte-derived macrophages: possible role in enhancing reverse cholesterol transport. Biochim. Biophys. Acta 1004 (1989) 292-299
81. Heeren J., Grewal T., Laatsch A., Rottke D., Rinninger F., Enrich C., and Beisiegel U. Recycling of apoprotein E is associated with cholesterol efflux and high density lipoprotein internalization. J. Biol. Chem. 278 (2003) 14370-14378
82. Garcia A., Barbaras R., Collet X., Bogyo A., Chap H., and Perret B. High-density lipoprotein 3 receptor-dependent endocytosis pathway in a human hepatoma cell line (HepG2). Biochemistry 35 (1996) 13064-13071
83. Klinger A., Reimann F.M., Klinger M.H., and Stange E.F. Clathrin-mediated endocytosis of high density lipoprotein3 in human intestinal Caco-2 cells. A post-embedding immunocytochemical study. Biochim. Biophys. Acta 1345 (1997) 65-70
84. Rogler G., Herold G., Fahr C., Fahr M., Rogler D., Reimann F.M., and Stange E.F. High-density lipoprotein 3 retroendocytosis: a new lipoprotein pathway in the enterocyte (Caco-2). Gastroenterology 103 (1992) 469-480
85. Smith J.D., Le Goff W., Settle M., Brubaker G., Waelde C., Horwitz A., and Oda M.N. ABCA1 mediates concurrent cholesterol and phospholipid efflux to apolipoprotein A-I. J. Lipid Res. 45 (2004) 635-644
86. Takahashi Y., and Smith J.D. Cholesterol efflux to apolipoprotein AI involves endocytosis and resecretion in a calcium-dependent pathway. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 11358-11363
87. Neufeld E.B., Stonik J.A., Demosky Jr. S.J., Knapper C.L., Combs C.A., Cooney A., Comly M., Dwyer N., Blanchette-Mackie J., Remaley A.T., Santamarina-Fojo S., and Brewer Jr. H.B. The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease. J. Biol. Chem. 279 (2004) 15571-15578
88. Chen W., Sun Y., Welch C., Gorelik A., Leventhal A.R., Tabas I., and Tall A.R. Preferential ATP-binding cassette transporter A1-mediated cholesterol efflux from late endosomes/lysosomes. J. Biol. Chem. 276 (2001) 43564-43569
89. Leventhal A.R., Chen W., Tall A.R., and Tabas I. Acid sphingomyelinase-deficient macrophages have defective cholesterol trafficking and efflux. J. Biol. Chem. 276 (2001) 44976-44983
90. Le Goff W., Peng D.Q., Settle M., Brubaker G., Morton R.E., and Smith J.D. Cyclosporin A traps ABCA1 at the plasma membrane and inhibits ABCA1-mediated lipid efflux to apolipoprotein A-I. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 2155-2161
91. Bared S.M., Buechler C., Boettcher A., Dayoub R., Sigruener A., Grandl M., Rudolph C., Dada A., and Schmitz G. Association of ABCA1 with syntaxin 13 and flotillin-1 and enhanced phagocytosis in tangier cells. Mol. Biol. Cell 15 (2004) 5399-5407
92. Engel T., Lueken A., Bode G., Hobohm U., Lorkowski S., Schlueter B., Rust S., Cullen P., Pech M., Assmann G., and Seedorf U. ADP-ribosylation factor (ARF)-like 7 (ARL7) is induced by cholesterol loading and participates in apolipoprotein AI-dependent cholesterol export. FEBS Lett. 566 (2004) 241-246
93. Szakacs G., Langmann T., Ozvegy C., Orso E., Schmitz G., Varadi A., and Sarkadi B. Characterization of the ATPase cycle of human ABCA1: implications for its function as a regulator rather than an active transporter. Biochem. Biophys. Res. Commun. 288 (2001) 1258-1264
94. Tanaka A.R., Abe-Dohmae S., Ohnishi T., Aoki R., Morinaga G., Okuhira K., Ikeda Y., Kano F., Matsuo M., Kioka N., Amachi T., Murata M., Yokoyama S., and Ueda K. Effects of mutations of ABCA1 in the first extracellular domain on subcellular trafficking and ATP binding/hydrolysis. J. Biol. Chem. 278 (2003) 8815-8819
95. Takahashi K., Kimura Y., Kioka N., Matsuo M., and Ueda K. Purification and ATPase activity of human ABCA1. J. Biol. Chem. 281 16 (2006) 10760-10768
96. Nofer J.R., Feuerborn R., Levkau B., Sokoll A., Seedorf U., and Assmann G. Involvement of Cdc42 signaling in apoA-I-induced cholesterol efflux. J. Biol. Chem. 278 (2003) 53055-53062
97. Zha X., Genest Jr. J., and McPherson R. Endocytosis is enhanced in Tangier fibroblasts: possible role of ATP-binding cassette protein A1 in endosomal vesicular transport. J. Biol. Chem. 276 (2001) 39476-39483
98. Von Eckardstein A., Langer C., Engel T., Schaukal I., Cignarella A., Reinhardt J., Lorkowski S., Li Z., Zhou X., Cullen P., and Assmann G. ATP binding cassette transporter ABCA1 modulates the secretion of apolipoprotein E from human monocyte-derived macrophages. FASEB J. 15 (2001) 1555-1561
99. Zhou X., Engel T., Goepfert C., Erren M., Assmann G., and von Eckardstein A. The ATP binding cassette transporter A1 contributes to the secretion of interleukin 1beta from macrophages but not from monocytes. Biochem. Biophys. Res. Commun. 291 (2002) 598-604
100. Hamon Y., Luciani M.F., Becq F., Verrier B., Rubartelli A., and Chimini G. Interleukin-1beta secretion is impaired by inhibitors of the Atp binding cassette transporter, ABC1. Blood 90 (1997) 2911-2915
101. Li Q., and Yokoyama S. Independent regulation of cholesterol incorporation into free apolipoprotein-mediated cellular lipid efflux in rat vascular smooth muscle cells. J. Biol. Chem. 270 (1995) 26216-26223
102. Yokoyama S. Assembly of high-density lipoprotein. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 20-27
103. Gillotte-Taylor K., Nickel M., Johnson W.J., Francone O.L., Holvoet P., Lund-Katz S., Rothblat G.H., and Phillips M.C. Effects of enrichment of fibroblasts with unesterified cholesterol on the efflux of cellular lipids to apolipoprotein A-I. J. Biol. Chem. 277 (2002) 11811-11820
104. Francone O.L., Subbaiah P.V., van Tol A., Royer L., and Haghpassand M. Abnormal phospholipid composition impairs HDL biogenesis and maturation in mice lacking Abca1. Biochemistry 42 (2003) 8569-8578
105. Langmann T., Klucken J., Reil M., Liebisch G., Luciani M.F., Chimini G., Kaminski W.E., and Schmitz G. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem. Biophys. Res. Commun. 257 (1999) 29-33
106. Lawn R.M., Wade D.P., Garvin M.R., Wang X., Schwartz K., Porter J.G., Seilhamer J.J., Vaughan A.M., and Oram J.F. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J. Clin. Invest. 104 (1999) R25-R31
107. Lin G., and Bornfeldt K.E. Cyclic AMP-specific phosphodiesterase 4 inhibitors promote ABCA1 expression and cholesterol efflux. Biochem. Biophys. Res. Commun. 290 (2002) 663-669
108. Oram J.F., Vaughan A.M., and Stocker R. ATP-binding cassette transporter A1 mediates cellular secretion of alpha-tocopherol. J. Biol. Chem. 276 (2001) 39898-39902
109. Haidar B., Mott S., Boucher B., Lee C.Y., Marcil M., and Genest Jr. J. Cellular cholesterol efflux is modulated by phospholipid-derived signaling molecules in familial HDL deficiency/Tangier disease fibroblasts. J. Lipid Res. 42 (2001) 249-257
110. Mendez A.J., Oram J.F., and Bierman E.L. Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. J. Biol. Chem. 266 (1991) 10104-10111
111. Fielding P.E., Nagao K., Hakamata H., Chimini G., and Fielding C.J. A two-step mechanism for free cholesterol and phospholipid efflux from human vascular cells to apolipoprotein A-1. Biochemistry 39 (2000) 14113-14120
112. Gelissen I.C., Harris M., Rye K.A., Quinn C., Brown A.J., Kockx M., Cartland S., Packianathan M., Kritharides L., and Jessup W. ABCA1 and ABCG1 synergize to mediate cholesterol export to ApoA-I. Arterioscler. Thromb. Vasc. Biol. 26 3 (2005) 534-540
113. Karten B., Campenot R.B., Vance D.E., and Vance J.E. Expression of ABCG1, but not ABCA1, correlates with cholesterol release by cerebellar astroglia. J. Biol. Chem. 281 (2006) 4049-4057
114. Oram J.F., and Heinecke J.W. ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol. Rev. 85 (2005) 1343-1372
115. Liu L., Bortnick A.E., Nickel M., Dhanasekaran P., Subbaiah P.V., Lund-Katz S., Rothblat G.H., and Phillips M.C. Effects of apolipoprotein A-I on ATP-binding cassette transporter A1-mediated efflux of macrophage phospholipid and cholesterol: formation of nascent high density lipoprotein particles. J. Biol. Chem. 278 (2003) 42976-42984
116. Stonik J.A., Remaley A.T., Demosky S.J., Neufeld E.B., Bocharov A., and Brewer H.B. Serum amyloid A promotes ABCA1-dependent and ABCA1-independent lipid efflux from cells. Biochem. Biophys. Res. Commun. 321 (2004) 936-941
117. Oram J.F., Wolfbauer G., Vaughan A.M., Tang C., and Albers J.J. Phospholipid transfer protein interacts with and stabilizes ATP-binding cassette transporter A1 and enhances cholesterol efflux from cells. J. Biol. Chem. 278 (2003) 52379-52385
118. Bortnick A.E., Rothblat G.H., Stoudt G., Hoppe K.L., Royer L.J., McNeish J., and Francone O.L. The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J. Biol. Chem. 275 (2000) 28634-28640
119. Arakawa R., Hayashi M., Remaley A.T., Brewer B.H., Yamauchi Y., and Yokoyama S. Phosphorylation and stabilization of ATP binding cassette transporter A1 by synthetic amphiphilic helical peptides. J. Biol. Chem. 279 (2004) 6217-6220
120. Zannis V.I., Chroni A., and Krieger M. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL. J. Mol. Med. 84 (2006) 276-294